Therma Bright Inc. announced that on May 31, 2023, representatives from Therma Bright Inc. and the U.S. Department of Health and Human Services (DHHS) engaged in productive discussions regarding the significance and potential impact of securing unique permanent Current Procedural Terminology (CPT®) /Healthcare Common Procedure Coding System (HCPCS) codes for the innovative Venowave device. The final decision regarding the issuance of these unique CPT and HCPCS codes will be released by the Centers for Medicare and Medicaid Services (CMS) in August 2023. In perfect alignment with these pivotal discussions, and in anticipation of a successful and final decision in August 2023, Therma Bright has continued to expand its U.S. ed distribution network and commercialization under the current nine (9) temporary CPT and HCPCS codes.

This expansion provides nationwide commercial access to clinical groups and hospital systems that are excited to provide widespread availability of the Venowave device to patients suffering from vascular disorders. Therma Bright firmly believes that although commercialization efforts under the temporary CPT and HCPCS codes may be of a transient nature, the outcomes from its most recent commercialization endeavors in the State of Texas are expected to materialize over upcoming quarters. The Company anticipates remarkable success and significant impact stemming from its endeavors in the vibrant Southern U.S, market.